0 results for 'Kasowitz Benson Torres'
Two things stand out about New York Supreme Court Justice Barbara Kapnick's ruling allowing ACA Financial to move forward with its fraud suit against Goldman Sachs. First, the ruling bucks the recent trend of courts dismissing suits by sophisticated parties involved in the CDO market. Second, Goldman is tripped up by its admissions in its $550 million settlement with the SEC.
Lawyers for Bank of New York Mellon at Paul Weiss failed to persuade a New York state judge to toss claims that BNY negligently subordinated noteholders to billions of dollars of additional senior debt when Lyondell acquired Basell in a disastrous 2007 leveraged buyout.
After cycling through nine sets of his own lawyers, Paul Ceglia, the man claiming to own at least half of Facebook, wants a judge to exile Facebook's lawyers at Gibson Dunn and strip them of their fees. Facebook's lawyers, meanwhile, want a judge to force Ceglia to turn over a letter from Kasowitz Benson they say shows once and for all that he's a fraud.
A California federal jury sided Friday with TransPerfect Solutions and its lawyers at Latham & Watkins and Kasowitz Benson in a patent showdown between rival website translation businesses. Competitor MotionPoint Corp. and its lawyers at Quinn Emanuel didn't prevail on any claims.
Partner Michael Shuster has a plan for getting around the daunting protections of foreign sovereign immunity. At stake are art works by El Greco and Velazquez.
N.J.'s Emcore, Tyco Say Executives Received Backdated Stock Options
Two New Jersey companies announced Wednesday that some of their executives have run afoul of stock option dating regulations. Emcore, a manufacturer of semiconductors and related devices, said that its CEO paid back $147,775 received from improperly backdated options, while its chief legal officer repaid $97,000. Tyco International said in an SEC filing that backdated options granted to a number of officers and directors would force it to restate financial statements by $252 million for 1999 through 2002.Drug Company Lodges RICO Suit, Charging Disinformation Campaign
A Canadian pharmaceutical company has filed a RICO suit in New Jersey state court, alleging that a hedge fund and stock analysts conspired to drive down its stock price to benefit short sellers. Backed by confidential e-mails and statements from disgruntled former employees-turned-witnesses, Biovail and its subsidiary, Biovail Pharmaceuticals, are seeking $4.6 billion in damages in the suit, which alleges the defendants conducted a disinformation campaign to hurt its stock.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
Data Management and Analytics: The Key to Success for Legal Operations
Brought to you by DiliTrust
Download Now
Small Law Firm Playbook: The Expert's Guide to Getting the Most Out of Legal Software
Brought to you by PracticePanther
Download Now
Strong & Hanni Solves Storage Woes--Learn How You Can, Too
Brought to you by Filevine
Download Now
Meeting the Requirements of California's SB 553: Workplace Violence Prevention
Brought to you by NAVEX Global
Download Now